Abstract
Innovations in ultra low-light CMOS bio-optical sensor design, combined with microfluidics technology can enable a new generation of low cost, portable molecular diagnostics platforms. This combination of technologies have been applied successfully in a miniaturized qPCR system, and a chemiluminescence microfluidic immunoassay platform to detect a variety of infectious pathogens. Cost reduction and miniaturization of molecular test enabled by this technology will have positive impact on global battle against infectious diseases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
